The FDA Amendments Act of 2007—User Fees and More

| 01 February 2008

The Food and Drug Administration Amendments Act of 2007 (FDAAA)1 is legislation that will have far-reaching impact on regulated industry. The act, signed into law on 27 September 2007, re-committed the medical device industry to user fees and averted a financial crisis for FDA that would have significantly reduced the agency's capacity to function. The user fees will provide predictable levels of funding for FDA for the next five years.2

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy